Remission may continue after termination of rIFNα-2b treatment for essential thrombocythemiaKASPARU, H; BERNHART, M; KRIEGER, O et al.European journal of haematology. 1992, Vol 48, Num 1, pp 33-36, issn 0902-4441Article

Trisomy 4: a specific karyotype anomaly in primary and secondary acute myeloid leukemiaWEBER, E; NOWOTNY, H; HAAS, O. A et al.Leukemia. 1990, Vol 4, Num 3, pp 219-221, issn 0887-6924Article

Association of GP40/CD7⁺ acute myelobalstic leukemia and chromosome 5 aberrationsLUTZ, D; KASPARU, H; NOWOTNY, H et al.Haematology and blood transfusion. 1990, Vol 33, pp 141-144, issn 0171-7111Article

Preliminary results of an induction combination regimen including fractionated anthracyclineKRIEGER, O; BERNHART, M; FIELDER, E et al.Bone marrow transplantation (Basingstoke). 1989, Vol 4, issn 0268-3369, p. 60, suppl. 3Conference Paper

The heterogeneity of CMMLKRIEGER, O; KANDIOLER, D; KASPARU, H et al.Bone marrow transplantation (Basingstoke). 1989, Vol 4, issn 0268-3369, p. 62, suppl. 3Conference Paper